BioSpace News Archive

TC Biopharm (Holdings) PLC (“TC Biopharm” or the “Company”) (NASDAQ: TCBP) (NASDAQ: TCBPW), today announced that Acute myeloid leukemia (AML) diagnoses have risen globally according to a recent study entitled, “EPR22-104: A Comparison of the Burden of Leukemia Amongst Various Regions of the World, 1990-2019.”

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a live webcast at 3:45 p.m. EDT on Monday, June 6, 2022, with Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, and Aamir Malik, Chief Business Innovation Officer, Executive Vice President, who will discuss expanding access and affordability to Pfizer’s medicines and vaccines.

Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today it has expanded its relationship with a leading Contract Development and Manufacturing Organization (CDMO), in the development of advanced cell and gene therapies, to a preferred partnership.

Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in The Benchmark Healthcare House Call Virtual 1x1 Conference being held on June 2, 2022.

Under the new Provizor brand umbrella, the company will continue to provide diversified health-care services.

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, held its annual general and special meeting (the “Meeting”) of its holders of common shares (the “Shareholders”) virtually on May 30, 2022.

The non-profit cancer research foundation Cancer Antibodies Inc., will be presenting their breakthrough method to detect unique antigenic targets on the surface of cancer cells at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced its participation in the upcoming 2022 American Transplant Congress held on June 4th to June 8th, 2022.

Ovensa Inc. and Celanese Corporation announced plans to collaborate on the long-acting controlled release of targeted therapeutics that address current performance, toxicity and resistance challenges in the market.

Quadrant Biosciences Inc., a developer of novel molecular diagnostics, announced that Dr. Funda Suer has joined the company as Executive Vice President of Clinical Diagnostics and CLIA Laboratory Director.